Publications by authors named "Kathleen Ann Day"

Claim this Profile
E
Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine.
Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki, Kathleen Ann Day, Taka Matsumura

J Pain Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.
Victoria A Reed, Jan K Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer

CNS Drugs· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.
Nicola C Savill, Jan K Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer

CNS Drugs· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of sexual and genitourinary treatment-emergent adverse events associated with atomoxetine treatment: a pooled analysis.
Angelo Camporeale, Kathleen Ann Day, Dustin Ruff, Jody Arsenault, David Williams

Drug Saf· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis